跳至主要内容
临床试验/NCT02413437
NCT02413437Unknown不适用

The Multi-center Study of Percutaneous Focal Liver Lesions Biopsy Guided by Contrast-Enhanced Ultrasound

Peking University Cancer Hospital & Institute1 个研究点 分布在 1 个国家目标入组 2,088 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
2,088
试验地点
1
主要终点
diagnostic accuracy

研究概览

简要总结

The purpose of this study is to estimate the clinical value of contrast-enhanced ultrasound in percutaneous biopsy for liver occupied lesion.

详细描述

The patients with liver neoplasms who need receive percutaneous biopsy were randomized into contrast-enhanced ultrasound(CEUS) group and conventional ultrasound(US) group.The aims include:

  1. Comparison the diagnostic accuracy rate, specificity and sensitivity between CEUS and US group.
  2. Comparison the diagnostic accuracy rate specificity and sensitivity between smaller(<3cm) and larger(≥3cm) nodule group.
  3. To explore operating strategy of contrast-enhanced ultrasound guided biopsy.
  4. To evaluate economic efficiency of contrast-enhanced ultrasound guided biopsy compared with conventional ultrasound guided biopsy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with liver occupied lesion who cannot be diagnosed by imaging examination or need pathological results

排除标准

  • severe anemia
  • PLT<60000/mm3,prothrombin activityprothrombin time activity<70%
  • women during menstruation, pregnancy, child birth and baby nursing period
  • patients with severe mental disorder
  • cardiopulmonary failure

结局指标

主要结局

diagnostic accuracy

时间窗: 12 months

diagnostic accuracy=(true positive+ ture negative)/number of parcitipants

次要结局

未报告次要终点

研究者

发起方
Peking University Cancer Hospital & Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kun Yan

Beijing Cancer Hospital

Peking University Cancer Hospital & Institute

研究点 (1)

Loading locations...

相似试验